Literature DB >> 26171712

[PROGNOSIS - The PROspective German NOn-CF BronchiectaSIS Patient Registry].

J Rademacher1, A de Roux2, F C Ringshausen1.   

Abstract

Bronchiectasis not due to cystic fibrosis (Non-CF bronchiectasis) represents a heterogeneous disorder with many different underlying diseases. Reliable and mature data referring to prevalence and incidence of Non-CF bronchiectasis in Germany are lacking. Bronchiectasis is often mentioned as rare or orphan disease, although it might be more often than supposed to be. Up to now (May 2015) there is no approved therapy for this disease in Germany. After some preliminary work the German bronchiectasis registry PROGNOSIS (The PROspective German NOn-CF bronchiectaSIS patient registry) will start recruiting patients by the beginning of July. The goals of PROGNOSIS are to build up a national, representative, prospective, observing (non-interventional) and longitudinal patient registry with at least 750 patients within three years in 25-35 centers, to evaluate important epidemiological questions. In addition a German-language guideline for diagnostic and management of Non-CF bronchiectasis will be developed in cooperation with the German respiratory society (DGP). © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 26171712     DOI: 10.1055/s-0034-1392254

Source DB:  PubMed          Journal:  Pneumologie        ISSN: 0934-8387


  4 in total

Review 1.  [Pseudomonas aeruginosa infections in chronic obstructive pulmonary disease : Role of long-term antibiotic treatment].

Authors:  G G U Rohde; T Welte
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743

2.  Computed tomography in adult patients with primary ciliary dyskinesia: Typical imaging findings.

Authors:  Sabine Dettmer; Felix Ringshausen; Jens Vogel-Claussen; Jan Fuge; Amir Faschkami; Hoen-Oh Shin; Nicolaus Schwerk; Tobias Welte; Frank Wacker; Jessica Rademacher
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

3.  Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement.

Authors:  Andrea Gramegna; Stefano Aliberti; Marco Confalonieri; Angelo Corsico; Luca Richeldi; Carlo Vancheri; Francesco Blasi
Journal:  Multidiscip Respir Med       Date:  2018-10-08

4.  Psychometric Validation of the German Translation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B)-Data from the German Bronchiectasis Registry PROGNOSIS.

Authors:  Laura Quellhorst; Grit Barten-Neiner; Andrés de Roux; Roland Diel; Pontus Mertsch; Isabell Pink; Jessica Rademacher; Sivagurunathan Sutharsan; Tobias Welte; Annegret Zurawski; Felix C Ringshausen
Journal:  J Clin Med       Date:  2022-01-15       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.